• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » U.K. genomics projects granted $505M

U.K. genomics projects granted $505M

August 1, 2014
CenterWatch Staff

Genomics England’s 100,000 Genomes Project has received a package of investment worth more than $505 million. The four year project focuses on new research to decode 100,000 human genomes—a patient’s personal DNA code.

Sequencing the genome of a person with cancer or someone with a rare disease will help scientists and doctors understand how disease works. The project has the potential to transform the future of health care, with new and better tests, drugs and treatment. It is expected to provide a lifeline to thousands of families affected by rare genetic diseases and cancers.

The Prime Minister has pledged that the U.K. will map 100,000 human genomes by 2017. Genomics England and Illumina have partnered to turn the plan into reality. Illumina’s services for whole genome sequencing have been secured in a deal worth $131.3 million. In turn, Illumina will invest $272 million into the work in England over four years, creating new knowledge and jobs in genome sequencing.

The Wellcome Trust has invested more than $1.7 billion in genomic research and has agreed to spend $45.4 million on a world class sequencing hub at its Genome Campus near Cambridge. This will house Genomics England’s operations alongside those of the Sanger Institute.

The Medical Research Council also has earmarked $40.4 million to help provide the computing power to make sure the data of participants will be properly analyzed, interpreted and made available to doctors and researchers securely.

NHS England has started the process of selecting the first NHS Genomics Medicine Centers. Successful centers will help to progress this ambitious project by inviting cancer and rare disease patients to take part by having their genome sequenced. NHS England has agreed to underwrite an NHS contribution of up to $33.7 million over the life of the project.

It is expected 40,000 NHS patients could benefit directly from the research. Ultimately, this work will pave the way for genomics-based medicine to become part of everyday practice throughout the NHS. Participation in the project will be based on consent, and people’s data will be protected through Genomics England’s secure data services.

Jeremy Farrar, director of the Wellcome Trust, said, “Understanding humanity’s genetic code is not only going to be fundamental to the medicine of the future. It is an essential part of medicine today. In rare congenital diseases, in cancer and in infections, genomic insights already are transforming diagnosis and treatment.”

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing